American Renal Associates Announces Outstanding Quality and Satisfaction Results
27 Fevereiro 2018 - 6:15PM
Business Wire
ARA’s Strength of Core Values and Unique
Physician-Partnership Model Delivers Superior Patient and Physician
Satisfaction Compared with National Averages
American Renal Associates Holdings, Inc. (NYSE: ARA) (“ARA” or
the “Company”), a leading provider of outpatient dialysis services,
today announced that the Company continues to build on its
exceptional track record of sustained outperformance in the areas
of patient quality and patient satisfaction, as well as physician
satisfaction, based on recently released results issued by the
Centers for Medicare & Medicaid Services (“CMS”) end-stage
renal disease (“ESRD”) Quality Incentive Program (“QIP”), as well
as others.
Joseph (Joe) Carlucci, Chairman and Chief Executive Officer,
said, “These outstanding results reflect the strength of our
operating model, the patient-centric culture of our organization
and our unwavering commitment to sustaining an environment that
promotes high-quality patient care and physician satisfaction. We
are proud to report continued outperformance in the areas of
quality and satisfaction, and we look forward to continuing to
share these results with our key stakeholders so they can
appreciate the benefits of our operating model.”
ARA’s QIP performance remains consistently higher than the
national average. ARA is fulfilling its commitment to provide
patients with high-quality care, as its QIP performance remains
consistently higher than the national average. QIP data from 2016,
the most recent performance year, show that only 10.5% of ARA’s
facilities with a QIP score will receive a payment reduction for
payment year 2018, as compared to the national average of 14.2% of
facilities that will receive a payment reduction for 2018. Over the
past four performance years of the QIP program, ARA’s facilities
have consistently exceeded the national average as a result of the
Company’s dedication to providing high-quality care that is
clinically integrated with the practice of its local physician
partners.
Most recent 2017 ICH-CAHPS performance again demonstrates
higher levels of satisfaction among ARA dialysis clinic
patients. The CMS In-Center Hemodialysis Consumer Assessment of
Healthcare Providers and Systems (“ICH-CAHPS”) survey is conducted
semi-annually and provides insight into how satisfied dialysis
patients are with their care. During Q4 2017, ARA received strong
results from the ICH-CAHPS survey conducted in mid-2017.
Specifically, ARA’s performance was rated 13%, 11% and 10% higher
than the national averages in terms of how satisfied patients were
with the dialysis clinic, the dialysis clinic staff and the
nephrologist associated with the facility where patients receive
their care, respectively.
ARA’s Core Values prioritize patient care and foster a
collaborative environment with physician partners that empower
staff to provide the best possible care for patients. As a result,
ARA enjoys low voluntary clinic staff turnover in comparison to
many other healthcare service providers, with year-end 2017 clinic
staff turnover of 7.8%. ARA believes that dialysis patients
appreciate the continuity of their local clinic staff caregivers,
and recognize that having experienced, stable staff can contribute
to better health outcomes.
ARA’s annual voluntary physician satisfaction survey results
highlight superior performance with physician stakeholders. For
the third consecutive year, ARA conducted a voluntary physician
survey that was administered by Press Ganey Associates, Inc. The
most recent 2017 physician satisfaction survey results placed ARA
in the 99th percentile for physician alignment and engagement,
which are key measures of satisfaction among clinic doctors and
indicate the clinician’s sense of pride and intention to remain
affiliated with their ARA clinic. ARA’s physician satisfaction, as
measured by the number of top box score responses, was in the 98th
percentile or above in a number of key areas such as the
physician’s satisfaction with their input into clinical decisions,
the quality of patient care and ARA leadership.
“As we reflect on the success of our operating model, and the
continued progress that the entire dialysis industry has made with
respect to improving patient outcomes, as evidenced by CMS data, we
join other leading providers in endorsing The Dialysis Patient
Access to Integrated-care, Empowerment, Nephrologists and Treatment
Services (PATIENTS) Demonstration Act. We believe that integrated
kidney care—led by nephrologists and care teams that can employ the
dialysis clinic as the patient’s medical home—can lead to even
better dialysis outcomes, greater access to transplants and lower
costs to the Medicare program,” concluded Carlucci.
About American Renal Associates
American Renal Associates Holdings, Inc. (NYSE: ARA) is a
leading provider of outpatient dialysis services in the United
States. As of September 30, 2017, ARA operated 217 dialysis clinic
locations in 25 states and the District of Columbia serving
approximately 15,200 patients with end stage renal disease. ARA
operates through a physician partnership model, in which it
partners with approximately 400 local nephrologists to develop, own
and operate dialysis clinics. ARA’s Core Values emphasize taking
good care of patients, providing physicians with clinical autonomy
and operational support, hiring and retaining the best possible
staff and providing best practices management services. For more
information about American Renal Associates, visit
www.americanrenal.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180227006409/en/
American Renal Associates Holdings, Inc.Darren Lehrich,
978-522-6063SVP Strategy & Investor
Relationsdlehrich@americanrenal.com
American Renal Associates (NYSE:ARA)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
American Renal Associates (NYSE:ARA)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024